Full Text View
Tabular View
No Study Results Posted
Related Studies
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
This study has been completed.
First Received: June 21, 2002   Last Updated: January 25, 2006   History of Changes
Sponsor: OSI Pharmaceuticals
Collaborator: NCIC Clinical Trials Group
Information provided by: OSI Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00040183
  Purpose

The purpose of this study is to determine if OSI-774 will improve overall survival when combined with a standard dose of the chemotherapy drug gemcitabine, to individuals with pancreatic cancer.


Condition Intervention Phase
Pancreatic Cancer
Drug: Tarceva (erlotinib HCl, OSI-774)
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: A Randomized Placebo Controlled Study of OSI-774 (Tarceva (TM)) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Resource links provided by NLM:


Further study details as provided by OSI Pharmaceuticals:

Estimated Enrollment: 500
Study Start Date: October 2001
Estimated Study Completion Date: September 2004
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Histologically or cytologically confirmed diagnosis of adenocarcinoma of the pancreas;cancer which is unresectable, locally advanced or metastatic.

Must have evidence of disease (clinical or radiological). Male or female, 18 years or older. Patients may have received prior radiation treatment for management of local disease providing that disease progression has been documented.

All toxicities have resolved, and the last fraction of radiation treatment was completed at least 4 weeks prior to randomization.

Patients may not have received prior chemotherapy, other then 5FU (+/- folic acid) or gemcitabine given concurrently with radiation treatment as a 'radiosensitiser.'

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00040183

  Hide Study Locations
Locations
United States, Arizona
Arizona Clinical Research Center
Tucson, Arizona, United States, 85715
United States, Arkansas
Highlands Oncology Group
Springdale, Arkansas, United States, 72764
United States, California
Metropolitan Hematology/Oncology Medical Group, Inc.
Los Angeles, California, United States, 90057
UCLA Medical Center
Los Angeles, California, United States, 90095
Kaiser Permanente
San Diego, California, United States, 92120
Loma Linda University Cancer Institute
Loma Linda, California, United States, 92354
Alta Bates Comprehensive Cancer Center
Berkeley, California, United States, 94704
United States, Connecticut
DeQuattro Community Cancer Center
Manchester, Connecticut, United States, 06040
Eastern Connecticut Oncology
Norwich, Connecticut, United States, 06360-2910
New Britain General Hospital
New Britain, Connecticut, United States, 06050
Carl and Dorothy Bennett Cancer Center
Stamford, Connecticut, United States, 06902-3628
United States, Florida
Oncology Hematology Group of South Florida
Miami, Florida, United States, 33176
Tampa General Hospital
Tampa, Florida, United States, 33606
Florida Cancer Specialists
Ft. Myers, Florida, United States, 34135-4251
Ocala Oncology
Ocala, Florida, United States, 34474
United States, Georgia
Atlanta Cancer Center
Atlanta, Georgia, United States, 30342
United States, Illinois
Hematology Oncology Associates of Illinois
Skokie, Illinois, United States, 60077
Onc/Hem Associates of Central Illinois
Peoria, Illinois, United States, 61602
Carle Cancer Center
Urbana, Illinois, United States, 61801
United States, Iowa
University of Iowa Hospital & Clinics
Iowa City, Iowa, United States, 52242
United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
United States, Kentucky
Norton Healthcare, Inc.
Louisville, Kentucky, United States, 40202
University of Kentucky
Lexington, Kentucky, United States, 40536-0098
United States, Louisiana
J Gurtler, Hematology and Oncology
Metairie, Louisiana, United States, 70006
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, United States, 70809
United States, Maryland
Sinai Hospital
Baltimore, Maryland, United States, 21215
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States, 21231
Annapolis Medical Specialists
Annapolis, Maryland, United States, 21401
United States, Massachusetts
Baystate Medical Center
Springfield, Massachusetts, United States, 01107
Berkshire Hematology & Oncology, PC
Pittsfield, Massachusetts, United States, 012018298
St Elizabeth Medical Center
Boston, Massachusetts, United States, 01235
New England Medical Center
Boston, Massachusetts, United States, 02111
United States, Minnesota
University of Minnesota
Minneapolis, Minnesota, United States, 55455
United States, Missouri
Kansas City Oncology and Hematology Group
Kansas City, Missouri, United States, 64111
United States, New Hampshire
New Hampshire Oncology-Hematology PA
Hooksett, New Hampshire, United States, 03106
United States, New Jersey
St Barnabas Medical Center
Livingston, New Jersey, United States, 07039
United States, New York
New York University School of Medicine
New York, New York, United States, 10016
St Luke's-Roosevelt Hospital
New York, New York, United States, 10019
Arena Oncology Associates
Great Neck, New York, United States, 11021
Stony Brook University Hospital
Stony Brook, New York, United States, 11794-8174
Interlakes Oncology & Hematology, P.C.
Rochester, New York, United States, 14623
United States, North Carolina
Presbyterian Hospital
Charlotte, North Carolina, United States, 28204
United States, North Dakota
Odyssey Research Services
Bismarck, North Dakota, United States, 58501
United States, Ohio
University Hospitals of Cleveland
Cleveland, Ohio, United States, 44106-7832
United States, Oregon
Chiles Research Cancer Center
Portland, Oregon, United States, 97213-2967
United States, Pennsylvania
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
Hematology & Oncolgy Assoc of NE PA
Dunmore, Pennsylvania, United States, 18512
University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States, 19104
Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States, 19106
United States, South Carolina
Charleston Hematology/Oncology
Charleston, South Carolina, United States, 29403
United States, Tennessee
Sarah Cannon Cancer Center
Nashville, Tennessee, United States, 37203
United States, Texas
Arlington Cancer Centre
Arlington, Texas, United States, 76012
Tyler Hematology Oncology PA
Tyler, Texas, United States, 75701
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Southwest Regional Cancer Center
Austin, Texas, United States, 78705
United States, Vermont
Green Mountain Oncology Group
Bennington, Vermont, United States, 05201
United States, Virginia
Hematology & Oncology Associates of Virginia, Ltd.
Richmond, Virginia, United States, 23226
United States, Washington
Southwest Washington Medical Center
Vancouver, Washington, United States, 98664
Western Washington Oncology Inc.
Olympia, Washington, United States, 98502
United States, Wisconsin
Oncology of Wisconsin
Milwaukee, Wisconsin, United States, 53215
Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina, CP 1181
Hospital Britanico
Buenos Aires, Argentina, CP 1280
Instituto Alexander Fleming
Buenos Aires, Argentina, CP 1426
Hospital Churruca Visca
Buenos Aires, Argentina, CP 1437
Centro Medico Confidence
Buenos Aires, Argentina, CP 1642
Instituto Oncologico Angel Roffo
Buenos Aires, Argentina, CP 1417
Australia, New South Wales
Newcastle Mater Hospital
HRMC Waratah, New South Wales, Australia, 2310
Prince of Wales Hospital
Randwick, New South Wales, Australia, 2031
Concord Hospital
Concord, New South Wales, Australia, 2139
Australia, South Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia, 5000
The Queen Elizabeth Hospital
Woodville South, South Australia, Australia, 5011
Ashford Cancer Centre
Ashford, South Australia, Australia, 5035
Australia, Victoria
Austin & Repatriation Medical Centre
Heidelberg, Victoria, Australia, 3084
Frankston Hospital
Frankston, Victoria, Australia, 3199
Belgium
Institute Jules Bordet
1000 Brussels, Belgium
Brazil, BA
Nucleo de Oncolgia da Bahia
Salvador, BA, Brazil, 40170-070
Brazil, Minas Gerais
Hospital Vera Cruz S/A
Barro Preto, Minas Gerais, Brazil, CEP 30190-130
Brazil, RS
Irmandade Santa Casa de Misericordia de Porto Alegre
Porto Alegre, RS, Brazil, CEP 90020-090
Brazil, SP
Hospital Israelita Albert Einstein
Sao Paulo, SP, Brazil, 05651-901
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Canada, British Columbia
BC Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada, V1Y 5L3
Pentincton Regional Hospital
Pentincton, British Columbia, Canada, V2A 3G6
Fraser Valley Cancer Centre
Surrey, British Columbia, Canada, V3V 1Z2
BCCA- Vancouver Island Centre
Victoria, British Columbia, Canada, V8R 6V5
BCCA VAncouver Centre
Vancouver, British Columbia, Canada, V5Z 4E6
Canada, Manitoba
CancerCare Manitoba (CCMB)
Winnipeg, Manitoba, Canada, R2H 2A6
Canada, New Brunswick
Saint John Regional Hospital
Saint John, New Brunswick, Canada, E2L 4L2
Canada, Newfoundland and Labrador
Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada, A1B 3V6
Canada, Nova Scotia
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 1V7
Canada, Ontario
Hotel Dieu Health Sciences HospitalNiagra
St. Catharines, Ontario, Canada, L2R 5K3
Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada, K1H 1C4
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9
Group Health Centre
Saulte Ste Marie, Ontario, Canada, P6B 1Y5
Kingston Regional Cancer Centre
Kingston, Ontario, Canada, K7L 5P9
Credit Valley Hospital
Mississauga, Ontario, Canada, L5M 2V8
Toronto-Sunnybrook Regional Cancer Center
Toronto, Ontario, Canada, M4N 3M5
Toronto East General Hospital
Toronto, Ontario, Canada, M4C 3E7
Hamilton Regional Cancer Centre
Hamilton, Ontario, Canada, L8V 5C2
St Joseph's Health Centre
Toronto, Ontario, Canada, M6R 1B5
London Regional Cancer Center
London, Ontario, Canada, N6A 4L6
Canada, Quebec
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada, H1T 2M4
Hopital Laval
Ste Foy, Quebec, Canada, G1V 4G5
Hopital Du Sacre-Coeur
Montreal, Quebec, Canada, H4J 2C5
Canada, Saskatchewan
Allan Blair Cancer Centre
Regina, Saskatchewan, Canada, S4T 7T1
Chile
Clinica Las Condes
Las Condes, Chile
Germany
Tumor Biology Center
Freiburg, Germany, D-79106
Charite Campus Virchow Klinikum
Berlin, Germany, 13353
Universitatskliniken des Saarlands Innere Medizin II
Hamburg, Germany, 66421
Medizinische Poliklinik der Universitaet Wurzburg
Wurzburg, Germany, 97070
Universitatskliniken des Saarlands
Homburg, Germany, 66421
Universitatsklinikum Essen
Essen, Germany, 45122
Innere Medizin Universitatsklinikum Heidelberg
69115 Heidelberg, Germany
Greece
Anticancer Hospital of Thessaloniki "THEAGENIO"
Thessaloniki, Greece, 546 39
District General Hospital of Thessaloniki "HIPPOKRATION"
Thessaloniki, Greece, 546 39
Israel
Kaplan Medical Center
Rehovot, Israel
Rambam Medical Center
Haifa, Israel, 31096
Rabin Medical Center (Belinson Campus)
Petach-Tiqva, Israel, 49100
Sourasky Medical Center (Ichikov)
Tel Aviv, Israel, 64239
Chaim Sheba Medical Center
Tel Hashomer, Israel, 52621
Italy
Azienda Ospedaliera Universitaria Policlinico A.O.V.P. Oncologia Medica
Palermo, Italy, 90127
Mexico
Instituto Nacional De Cancerologia
Mexico City, Mexico, 14000
New Zealand
Auckland Hospital
Auckland, New Zealand, 92019
Christchurch Hospital Clinical Oncology Hospital
Christchurch, New Zealand
Poland
Dolnoslaskie Centrum Onkologii
Wroclaw, Poland, 53-413
Great Poland Cancer Centre
Poznan, Poland, 61 866
Romania
Clinical County Hospital Sibiu
Sibiu, Romania, 2400
Oncology Institute Ion Chiricuta
Cluj Napoca, Romania, 3400
St. Spiridon University Hospital
Iasi, Romania, 6600
Singapore
National University Hospital
Singapore, Singapore, 119074
Singapore General Hospital
Singapore, Singapore, 169608
National Cancer Centre
Singapore, Singapore, 169610
United Kingdom
St. Bartholomews Hospital
London, United Kingdom, EC1A 7BE
The Princess Royal Hospital
Hull, United Kingdom, HU8 9HE
Department of Medical Oncology
Manchester, United Kingdom, M20 4BX
North Middlesex Hospital
London, United Kingdom, N18 1QX
Newcastle General Hospital
Newcastle upon Tyne, United Kingdom, NE4 6BE
United Kingdom, Oxfordshire
ICRF Medical Oncology Unit
Oxford, Oxfordshire, United Kingdom, OX3 7LJ
United Kingdom, Wales
Velindre Hospital
Cardiff, Wales, United Kingdom, CF14 2TL
United Kingdom, West Midlands
Deanesly Centre
Wolverhampton, West Midlands, United Kingdom, WV10 0QP
Russell's Hall Hospital Department of Oncology Georgina Unit
Dudley, West Midlands, United Kingdom, DY8 5QX
Sponsors and Collaborators
OSI Pharmaceuticals
NCIC Clinical Trials Group
  More Information

Additional Information:
No publications provided

Study ID Numbers: OSI-774-PA3
Study First Received: June 21, 2002
Last Updated: January 25, 2006
ClinicalTrials.gov Identifier: NCT00040183     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by OSI Pharmaceuticals:
Tarceva, EGFR, erlotinib, OSI-774

Additional relevant MeSH terms:
Erlotinib
Antimetabolites
Anti-Infective Agents
Digestive System Neoplasms
Antimetabolites, Antineoplastic
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Pancreatic Neoplasms
Physiological Effects of Drugs
Endocrine System Diseases
Enzyme Inhibitors
Protein Kinase Inhibitors
Immunosuppressive Agents
Antiviral Agents
Pharmacologic Actions
Neoplasms
Neoplasms by Site
Digestive System Diseases
Radiation-Sensitizing Agents
Therapeutic Uses
Pancreatic Diseases
Gemcitabine
Endocrine Gland Neoplasms

ClinicalTrials.gov processed this record on November 22, 2009